Probably the best
healthcare consultancy
in the Nordics

01

Market Access, Health Economics & Evidence Generation – we got you!

02

Local insights with global impact!

03

We love our clients – that’s why we measure success in trust not transactions

Curious about the Impact of EU JCA in the Nordics?

Want to hear more about the EU JCA.

Who are we

We want to be the Go-To Partner for Evidence Generation & Market Access by:

  • Delivering the solutions that provides Highest Possible Value for our clients
  • Delivering Higher Quality than everyone else
  • Ensuring Predictable and Seamless processes
  • Being Nice to Work with

We believe, we cannot do this without Innovation, Creativity and a Passion to make a difference for our clients.

It is not always easy to practice what you preach, but we try to.

Our offerings

Market Access

Market Access is Tricky, Otherwise You Probably Wouldn’t Be Reading This.

Luckily, We Know All The Ins And Outs Of Market Access – And We Would Love To Help You!

Health Technology Assessments (HTA)

Developing HTA submissions – just follow the guidelines, right?

It is not as simple as that if you want to increase the likelihood of success.

We know the whats and hows – just look at our name!

Health Economics

No matter if you need to build an advanced global CE model, a pragmatic payer tool or simply conduct a local adaptation – We are your go-to partner.

Disclaimer: we only build models that generate value and impact.

Evidence generation & RWE

It is crucial to utilise the best available evidence and in the best possible way.

Are you confident you have done this?

We can help you answer this – and we have evidence to support this claim.

Our work

A roadmap of innovative market access approaches in the Nordics

In preparation to optimise the likelihood of successful launches for selected pipeline assets, a major pharmaceutical company, wished to have a roadmap of innovative ways to gain access and fully understand the competitive landscape in the Nordics.

Building on our vast experience within innovative access approaches, we performed targeted reviews to identify and summarise innovative market access routes in the Nordics. Additionally, to capture information that was not publicly available and to understand future opportunities and trends, we conducted interviews with payers and HTA bodies (e.g. Amgros, TLV) across the Nordics.

The latest

Do you want to gain insight on market trends? Make sure to read the latest news from NHTA.

Our client partners

We Support Major Pharma, Small Biotech, Medtech Companies, Universities, And Public Bodies. Reach Out So We Can Also Support You!

Here Is a Small Selection of Our Clients:

How do payers assess new drugs with limited long-term data?